AVITA Medical, Inc.
RCEL · XNASCIK 1762303fmd_1XP05E3DS31S3T29KT717S65ACManufacturing · Surgical & Medical Instruments & ApparatusTemplate: Standard
Coverage: Jul 01, 2016 to Sep 30, 2026, 35 periods
| Line item | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|
| Total revenues | 1 | 5 | 14 | 29 | 34 | 50 | 64 | 72 |
| Cost of revenue | 1 | 1 | 3 | 6 | 6 | 8 | 9 | 13 |
| Gross profit | 0 | 4 | 11 | 23 | 28 | 42 | 55 | 59 |
| Provision for credit losses | 0 | 0 | 0 | 0 | (0) | 0 | 0 | (0) |
| Research and development | 6 | 8 | 9 | 15 | 14 | 21 | 20 | 21 |
| Selling, general and administrative | 14 | 28 | 49 | 37 | 45 | 66 | 91 | 81 |
| Total operating expenses | 22 | 36 | 58 | 52 | 59 | 86 | 112 | 101 |
| Operating income | (14) | (26) | (43) | (27) | (28) | (43) | (57) | (43) |
| Interest expense | 0 | 0 | 0 | 0 | 0 | 1 | 5 | 5 |
| Other non-operating income (expense) | – | – | – | – | 1 | 8 | 0 | (1) |
| Income before taxes | (14) | (25) | (42) | (27) | (27) | (35) | (62) | (49) |
| Income tax expense | (1) | (0) | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income from continuing operations | (13) | (25) | (42) | (27) | (27) | (35) | (62) | (49) |
| Net income | (13) | (25) | (42) | (27) | (27) | (35) | (62) | (49) |